Cargando…

Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis

BACKGROUND: Study on the relationship between glutathione-S-transferase Pi 1 (GSTP1) and P16 promoter region methylation and the risk of hepatitis B virus-related hepatocellular carcinoma (HBV-related HCC) has produced inconsistent results. OBJECTIVES: To assess the correlation between GSTP1 and P16...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qin, Deng, Cunliang, Zhang, Ting, Li, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140744/ https://www.ncbi.nlm.nih.gov/pubmed/30254471 http://dx.doi.org/10.2147/OTT.S168444

Ejemplares similares

Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma
por: Chen, Yao-Li, et al.
Publicado: (2010)

The Effects of Lycopene on the Methylation of the GSTP1 Promoter and Global Methylation in Prostatic Cancer Cell Lines PC3 and LNCaP
por: Fu, Li-Juan, et al.
Publicado: (2014)

Association between gene methylation and HBV infection in hepatocellular carcinoma: A meta-analysis
por: Zhang, Cheng, et al.
Publicado: (2019)

Impact of the Location of CpG Methylation within the GSTP1 Gene on Its Specificity as a DNA Marker for Hepatocellular Carcinoma
por: Jain, Surbhi, et al.
Publicado: (2012)

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis
por: Wu, T, et al.
Publicado: (2011)

Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
por: Yin, Wen, et al.
Publicado: (2015)

Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA
por: Sheng, Xianneng, et al.
Publicado: (2017)

Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma
por: Chang, Te-Sheng, et al.
Publicado: (2016)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma
por: Sun, Gaofeng, et al.
Publicado: (2017)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Genomic analysis quantifies pyroptosis in the immune microenvironment of HBV-related hepatocellular carcinoma
por: Li, Jiarui, et al.
Publicado: (2022)

The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma
por: Zhang, Cunzhen, et al.
Publicado: (2022)

Association of CD44 polymorphisms and susceptibility to HBV‐related hepatocellular carcinoma in the Chinese population
por: Deng, Yan, et al.
Publicado: (2019)

Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
por: Csepregi, Antal, et al.
Publicado: (2010)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes
por: Sun, Jianping, et al.
Publicado: (2019)

SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2015)

Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma
por: Ma, Linkun, et al.
Publicado: (2019)

Correction: Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma
por: Chang, Te-Sheng, et al.
Publicado: (2017)

lncRNA SNHG9 Promotes Cell Proliferation, Migration, and Invasion in Human Hepatocellular Carcinoma Cells by Increasing GSTP1 Methylation, as Revealed by CRISPR-dCas9
por: Ye, Shanting, et al.
Publicado: (2021)

Investigational drugs with dual activity against HBV and HIV (Review)
por: Sun, Shiyu, et al.
Publicado: (2021)

Studies on the correlation between mutation and integration of HBV in hepatocellular carcinoma
por: Cui, Xiaofang, et al.
Publicado: (2020)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Identification Of Novel lncRNAs For Detection Of HBV-Associated Hepatocellular Carcinoma
por: Li, Yuwei, et al.
Publicado: (2019)

Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer
por: ZHANG, WEIJIE, et al.
Publicado: (2015)

DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis
por: Yoon, Hyung-Yoon, et al.
Publicado: (2012)

GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
por: Martignano, Filippo, et al.
Publicado: (2016)

Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation
por: Chen, Jian-Liang, et al.
Publicado: (2019)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis
por: Luo, Xiaojun, et al.
Publicado: (2019)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients
por: Thi Cam Huong, Nguyen, et al.
Publicado: (2022)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”
por: Mo, Han-Yue, et al.
Publicado: (2016)

Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma
por: Zhang, Weilu, et al.
Publicado: (2020)

Anillin is required for tumor growth and regulated by miR-15a/miR-16-1 in HBV-related hepatocellular carcinoma
por: Lian, Yi-Fan, et al.
Publicado: (2018)

Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2017)

Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis
por: Bi, Jingfeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lfj7didnq98ao84qjvcmf62mq8